Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Fabtech Technologies IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 230.35 Cr
Profile
Price Range 181  to  191 per share
Profile
Min Investment ₹191
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are a global company headquartered in India, specializing in turnkey engineering solutions forpharmaceuticals, biotech and healthcare companies. We provide extensive technical expertise and infrastructureto deliver comprehensive solutions for establishing aseptic manufacturing facilities, encompassing everythingfrom design to certification. Our footprint spans more than 62 countries globally and across regions including butnot limited to, Middle East, Africa, Asia, Europe, Latin America, North America, etc. (Source: CRISIL Report).Our Company has presence across some of the key emerging economies like Bangladesh, Egypt, Ethiopia, India,Kenya, Kingdom of Saudi Arabia, Morocco, Nicaragua, Nigeria, South Africa, Turkey and Tanzania (Source:CRISIL Report). We build pharmaceutical, biotech and healthcare capabilities by offering comprehensive start tofinish solutions encompassing designing, engineering, procurement, installation and testing of selectpharmaceutical equipment for a wide range of customers. Read More

Basic Info

Face Value 10 per share

Price 181  to  191 per share

P/E (x) 13.4

Sales( Cr.) 327

PAT( Cr.) 46

EPS 14.3

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Aasif Ahsan Khan Hemant Mohan Anavkar Aarif Ahsan Khan Manisha Hemant Anavkar

Pre Issue Share Holding 94.61%

Post Issue Share Holding 68.94%

Listing Details:

Listing Price: 191

Listing Gain: 0%

Current Price: 155.4

Gain On Issue: 155.4 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Sep 29, 2025
Closing Date Oct 01, 2025
Allotment Oct 02, 2025
Refund Oct 03, 2025
Delivery of Shares Oct 03, 2025
Listing Date Oct 06, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 75 14,325
Retail (Max) 13 975 186,225
S-HNI (Min) 14 1050 200,550
S-HNI (Max) 69 5175 988,425
B-HNI (Min) 70 5250 1,002,750

Objective of the Issue

1. Funding working capital requirements of our Company 2. Pursuing inorganic growth initiatives through acquisitions 3. General Corporate Purposes

Issue

Category Nos Bid Bid (x)
QIB 6002526 12114600 2x
NII 1800759 3542250 2x
Retail 4201770 8755500 2.1x
EMP 54945 110400 2x
Total 12060000 24522750 2x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Fabtech Technologies Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 257 194 226 327
Other Income 3 6 4 9
Total Income 260 200 231 336
Total Expenditure 225 169 191 288
Operating Profit 35 31 39 48
Interest 3 5 3 3
Depreciation 2 2 2 3
Exceptional Income / Expenses 0 0 0 18
Profit Before Tax 31 28 36 60
Provision for Tax 8 6 9 14
Profit After Tax 23 22 27 46
Adjustments 0 0 0 0
Profit After Adjustments 23 22 27 46
Adjusted Earnings Per Share 7.7 7.1 8.4 14.3

Fabtech Technologies Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 67 89 132 173
Minority's Interest 0 0 -0 -0
Borrowings 1 1 0 1
Other Non-Current Liabilities 2 0 0 25
Total Current Liabilities 101 122 135 225
Total Liabilities 171 213 267 424
Fixed Assets 5 4 22 94
Other Non-Current Assets 20 28 4 16
Total Current Assets 147 181 229 308
Total Assets 171 213 267 424

Fabtech Technologies Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 14 11 11 29
Cash Flow from Operating Activities -3 -14 61 -36
Cash Flow from Investing Activities -9 2 -30 -20
Cash Flow from Financing Activities 8 12 -13 36
Net Cash Inflow / Outflow -4 -0 18 -20
Closing Cash & Cash Equivalent 11 11 29 9

Fabtech Technologies Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 7.66 7.09 8.4 14.34
CEPS(Rs) 8.19 7.71 9.04 15.15
DPS(Rs) 0 0 0 1.5
Book NAV/Share(Rs) 21.99 29.03 40.71 53.44
Core EBITDA Margin(%) 12.5 12.95 15.41 11.87
EBIT Margin(%) 13.42 17.01 17.07 19.47
Pre Tax Margin(%) 12.21 14.4 15.82 18.5
PAT Margin (%) 9.13 11.21 12.04 14.22
Cash Profit Margin (%) 9.76 12.2 12.96 15.02
ROA(%) 13.73 11.33 11.34 13.43
ROE(%) 34.84 27.8 24.65 30.46
ROCE(%) 39.96 31.45 29.14 34.43
Receivable days 119.66 173.02 158.24 138.21
Inventory Days 9.23 22.36 37.53 49.55
Payable days 136.09 208.75 178.81 164.44
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) -0.01 0.07 -0.15 0.16
EV/Core EBITDA(x) -0.09 0.42 -0.85 1.08
Net Sales Growth(%) 0 -24.65 16.69 44.46
EBIT Growth(%) 0 -4.5 17.16 64.74
PAT Growth(%) 0 -7.43 25.23 70.67
EPS Growth(%) 0 -7.43 18.47 70.68
Debt/Equity(x) 0.28 0.39 0.07 0.32
Current Ratio(x) 1.46 1.48 1.7 1.37
Quick Ratio(x) 1.39 1.34 1.48 1.1
Interest Cover(x) 11.06 6.51 13.59 20.04
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 45% 8% 0% 0%
Operating Profit CAGR 23% 11% 0% 0%
PAT CAGR 70% 26% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 30% 28% 29% 29%
ROCE Average 34% 32% 34% 34%

Company Contact Information

Fabtech Technologies Ltd.

Neetu Sunil Buchasia

+91 226 159 2900

cs@fabtechnologies.com

715, Janki Centre Off. Veera Desai Road Andheri (West)

IPO Lead Manager(s)

Fabtech Technologies Ltd.

Unistone Capital Pvt Ltd.

Registrar Info

Fabtech Technologies Ltd.

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093 (old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059 Tel: + 91 21 626 38200 Fax:

91-022-62638200

91-022-62638299

Investor@bigshareonline.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp